An official mentioned that Siddaramaiah had previously received treatment for a ligament tear, which resurfaced on Sunday.

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...